Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients in a Late-Breaker Session at the EASL Conference

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access